KALM Therapeutics provides non-steroidical treatment for eczema and psoriasis.
KALM Therapeutics has raised $590K in total funding. The most recent round was Seed. The last funding was announced in August 2024.
KALM Therapeutics is headquartered in Huntsville, United States.
KALM Therapeutics provides non-steroidical treatment for eczema and psoriasis.
KALM Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"KALM Therapeutics — Funding & Investors." VCBacked, August 9, 2024, https://www.vcbacked.co/company/kalm-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). KALM Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/kalm-therapeutics
{{cite web |title=KALM Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kalm-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated